2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO3] Mini-Oral Session 3　Gastrointestinal Cancer 1（Upper GI Tract 1）
【E】

Thu. Feb 17, 2022 1:20 PM - 2:10 PM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair：Daisuke Takahari（Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital of Japanese Foundation For Cancer Research），Shuichi Hironaka（Medical Oncology, Saitama Medical University International Medical Center）

[MO3-6] Safety and early efficacy of nivolumab plus trastuzumab with FU plus oxaliplatin for HER2-positive gastric cancer

○Hirokazu Shoji1, Daisuke Takahari2, Keiko Minashi3, Hiroki Hara4, Keisho Chin2, Akira Ooki2, Mariko Ogura2, Izuma Nakayama2, Ken Kato1, Satoru Iwasa1, Hidekazu Hirano1, Yusuke Amanuma3, Naoki Ishizuka5, Narikazu Boku1, Kensei Yamaguchi2 (1.Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 2.Department of Gastroenterology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3.Clinical Trial Promotion Department, Chiba Cancer Center, 4.Department of Gastroenterology, Saitama Cancer Center, 5.Department of Clinical Trial Planning and Management, Cancer Institute Hospital of Japanese Foundation for Cancer Research)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password